Literature DB >> 17931789

Lysophospholipid signaling: beyond the EDGs.

William J Valentine1, Yuko Fujiwara, Ryoko Tsukahara, Gabor Tigyi.   

Abstract

As our understanding of the myriads of biological effects caused by lysophospholipids expands, we become witnesses to another miracle of nature that has endowed the simplest lysophospholipids with functions seemingly ubiquitous to every mammalian cell. A decade after the discovery of the EDG family lysophospholipid receptors, the field has gained unimaginable impetus explaining the biological effects of sphingosine-1-phosphate and lysophosphatidic acid (LPA). The discovery of LPA receptors in the purinergic G-protein-coupled receptor (GPCR) gene cluster refined this picture and added complexity to our concepts of lysophospholipid cell signaling. The intracellular lysophospholipid targets - identified and not yet identified - make us realize the dual mediator and second messenger roles of lysophospholipids. In this paper we provide new data obtained concerning LPA-elicited responses using cell lines naturally lacking or intentionally knocked out of many of the known LPA GPCR, widely used by investigators in the field as cells with LPA receptor "null background." Our observations raise caution about the lack of LPA responsiveness in these cells and underline the unprecedented complexity and redundancy of lysophospholipid-evoked cellular responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931789      PMCID: PMC2751795          DOI: 10.1016/j.bbagen.2007.08.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

1.  A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.

Authors:  N Fukushima; Y Kimura; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

2.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

Authors:  M J Lee; J R Van Brocklyn; S Thangada; C H Liu; A R Hand; R Menzeleev; S Spiegel; T Hla
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

3.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

Authors:  W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.

Authors:  K Bandoh; J Aoki; H Hosono; S Kobayashi; T Kobayashi; K Murakami-Murofushi; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

5.  Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.

Authors:  S An; T Bleu; O G Hallmark; E J Goetzl
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

6.  EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue.

Authors:  M H Gräler; G Bernhardt; M Lipp
Journal:  Genomics       Date:  1998-10-15       Impact factor: 5.736

7.  Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.

Authors:  S An; T Bleu; Y Zheng; E J Goetzl
Journal:  Mol Pharmacol       Date:  1998-11       Impact factor: 4.436

8.  N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.

Authors:  K Liliom; R Bittman; B Swords; G Tigyi
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

9.  Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation.

Authors:  J C Mills; N L Stone; J Erhardt; R N Pittman
Journal:  J Cell Biol       Date:  1998-02-09       Impact factor: 10.539

10.  Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.

Authors:  J H Hecht; J A Weiner; S R Post; J Chun
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

View more
  9 in total

1.  Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.

Authors:  Luciana Nogaroli; Larra M Yuelling; Jameel Dennis; Karen Gorse; Shawn G Payne; Babette Fuss
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

2.  Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.

Authors:  Molly K Altman; Vashisht Gopal; Wei Jia; Shuangxing Yu; Hassan Hall; Gordon B Mills; A Cary McGinnis; Michael G Bartlett; Guowei Jiang; Damian Madan; Glenn D Prestwich; Yong Xu; Michael A Davies; Mandi M Murph
Journal:  Mol Cancer       Date:  2010-06-09       Impact factor: 27.401

Review 3.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

4.  Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.

Authors:  Yutaka Hasegawa; Mandi Murph; Shuangxing Yu; Gabor Tigyi; Gordon B Mills
Journal:  Mol Oncol       Date:  2008-06       Impact factor: 6.603

Review 5.  Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.

Authors:  Larra M Yuelling; Babette Fuss
Journal:  Biochim Biophys Acta       Date:  2008-04-29

Review 6.  Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation.

Authors:  Mandi M Murph; Giang H Nguyen; Harish Radhakrishna; Gordon B Mills
Journal:  Biochim Biophys Acta       Date:  2008-04-29

Review 7.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

8.  Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA).

Authors:  Eun Young Park; Andrius Kazlauskas
Journal:  Biosci Rep       Date:  2012-08       Impact factor: 3.840

9.  Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.

Authors:  Vivek Rai; Fatouma Touré; Seth Chitayat; Renjun Pei; Fei Song; Qing Li; Jinghua Zhang; Rosa Rosario; Ravichandran Ramasamy; Walter J Chazin; Ann Marie Schmidt
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.